189 related articles for article (PubMed ID: 20306657)
1. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
2. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.
Badran A; Yoshida A; Wano Y; Imamura S; Kawai Y; Tsutani H; Inuzuka M; Ueda T
Anticancer Res; 2003; 23(1B):589-92. PubMed ID: 12680151
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in the progression of chronic myeloid leukemia: a sequential study in 16 patients.
Hernández-Boluda JC; Bellosillo B; Vela MC; Colomer D; Alvarez-Larrán A; Cervantes F
Leuk Lymphoma; 2005 May; 46(5):717-22. PubMed ID: 16019509
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression in chronic myeloid leukemia.
Conte E; Stagno F; Guglielmo P; Scuto A; Consoli C; Messina A
Cancer Lett; 2005 Jul; 225(1):105-10. PubMed ID: 15922862
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial cells are increased in chronic myeloid leukemia blast crisis.
Godoy CR; Levy D; Giampaoli V; Chamone DA; Bydlowski SP; Pereira J
Braz J Med Biol Res; 2015 Jun; 48(6):509-14. PubMed ID: 25831205
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
7. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
[TBL] [Abstract][Full Text] [Related]
8. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
9. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
11. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
12. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
13. [Expression of XIAP gene in chronic myeloid leukemia and its clinical significance].
Wang SG; Guan HZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):321-3. PubMed ID: 21518480
[TBL] [Abstract][Full Text] [Related]
14. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 and disease transformation in chronic myeloid leukemia: A Northeast Indian population study.
Sharma K; Singh U; Rai M; Shukla J; Gupta V; Narayan G; Kumar S
J Cancer Res Ther; 2020; 16(1):30-33. PubMed ID: 32362606
[TBL] [Abstract][Full Text] [Related]
17. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
[TBL] [Abstract][Full Text] [Related]
18. [Expression of beta-Catenin Gene in CML and its relationship with bcr/abl].
Li ZJ; Qiu LG; Li X; Mai YJ; Wang GR; Yu Z; Wang YF; Li CH; Li Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):931-5. PubMed ID: 17956664
[TBL] [Abstract][Full Text] [Related]
19. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in Philadelphia positive chronic myeloid leukaemia.
Rasoul NA; Elhalawani N; Nafae MH; Elkaffash DM; Mourad ZI
Egypt J Immunol; 2004; 11(1):1-8. PubMed ID: 15724380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
